1-2 of 2
Philippe Bourget, MD PhD
Close
Sort by
Journal Articles

Treatment of Advanced Systemic Mastocytosis with PKC412: The French Compassionate Use Programme Experience and Historical Comparison

Marie-Olivia Chandesris, MD, Gandhi Damaj, MD PhD, Danielle Canioni, MD, Chantal Brouzes, MD, Laure Cabaret, Katia Hanssens, Isabelle Durieu, MD PhD, Stéphane Durupt, MD, Sophie Besnard, MD, Odile Beyne-Rauzy, MDPhD, David Launay, MDPhD, Aurélie Schiffmann, MD, Mathilde Niault, MD, Dana Ranta, MD, Philippe Agape, MD, Cyrill Faure, MD, Sylvain P Chantepie, MD, Nicolas Daguindau, MD, Philippe Bourget, MD PhD, Patrice Dubreuil, Olivier Lortholary, MD PhD, Olivier Hermine, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3193.
https://doi.org/10.1182/blood.V124.21.3193.3193
Published: 2014
Journal Articles

Development and Validation of a Sensitive Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Assay for the Simultaneous Quantification of Midostaurin (PKC412) and Its Two Major Metabolites: A Suitable Tool for the Monitoring of the Drug in Patients Suffering From Advanced Systemic Mastocytosis

Philippe Bourget, MD, PhD, Marie-Olivia Chandesris, MD, Alexandre Amin, Fabrice Vidal, Christophe Merlette, Isabelle Hirsh, Ana Carvalhosa, Agnes Mogenet, Christine Broissand, MD, Bérénice Giraud, Laurent Frenzel, Gandhi Damaj, Olivier Lortholary, MD, PhD, Olivier Hermine, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4913.
https://doi.org/10.1182/blood.V120.21.4913.4913
Published: 2012